extension studies with a median duration of approximately 2. years including 4843 patients and over 13000 patient-years of therapy, the observed rate of malignancies, other than lymphoma and non- melanoma skin cancers is approximately 13.6 per 1000 patient years.
pe patsienti ning milles ravikestus ületab 13000 patsientaastat, on pahaloomuliste kasvajate (v. a lümfoomid või mittemelanoom nahavähid) esinemissageduseks ligikaudu 13, 6 juhtu 1000 patsientaasta kohta.